CRSP — CRISPR Therapeutics AG | Setup 8-12 Jun 2026

CRSP

CRISPR Therapeutics AG

Updated: 2026-06-13 · [ 8-12 Jun 2026 ]

Stock · US

Inside composite NTZ, transitioning bias

SCORE IQS Lite

30/100

Compressed phaseCompressed Ordinary phaseOrdinary Stretched phaseStretched Mature phaseMature

Structure 1W 17

Momentum 1D 8

Ichimoku 1W 2

CMF 1D 3

Delta 0

IQS Lite Components · What they measure

Structure 1W — MA alignment and solidity of the underlying trend

Momentum 1D — Directional strength and momentum acceleration

Ichimoku 1W — Price position relative to the Kumo cloud

CMF 1D — Capital pressure: inflows or outflows

Delta — IQS score change vs previous week (W-1)

Each axis ranges 0-20 pt · sum = total IQS Lite (0-100)

Executive View

CRSP remains in consolidation with daily MACD showing strong bearish pressure. The price is confined between 46.94 and 52.66, lacking directional conviction. Current setup favours caution; our view remains neutral, pending confirmation on breakdown or breakout above key technical levels.

📅 Earnings: 2026-08-10

Chart · 12-month trend

Charts provided by TradingView

Full in-depth analysis with precise levels and trade setup is reserved for ★ GOLD